Resona Pharmaceutical Limited logo

Resona Pharmaceutical Limited

Produces various pharmaceutical medicines, including leflunomide, morphine sulphate, and paracetamol, since 2021.
2021 | Salem, Tamil Nadu (India) | Active

Last Updated:

November 16, 2024
HomeCompanyResona Pharmaceutical Limited

Who are the key members and board of directors at Resona Pharmaceutical?

Board Members(3)

NameDesignationAppointment DateStatus
Duraisami Sathishkannan In Director 23-Mar-2021Current
Suresh Vijay In Director 23-Mar-2021Current
Kuppuraj Shanmugavadivu In Director 23-Mar-2021Current

Financial Performance of Resona Pharmaceutical.

Resona Pharmaceutical Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 29.54% increase. The company also saw a substantial improvement in profitability, with a 314.92% increase in profit. The company's net worth Soared by an impressive increase of 119.74%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
29.54%
Revenue from Operations
29.54%
Total Assets
1.19%
Profit or Loss
314.92%
Net Worth
119.74%
EBITDA
294.03%

Related Corporates (Common Directorship)

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Resona Pharmaceutical?

Resona Pharmaceutical has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Resona Pharmaceutical

Recent activity within the organization

  • Annual General Meeting

    Resona Pharmaceutical Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

    30 Sep 2023

  • Balance Sheet

    Resona Pharmaceutical Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Coimbatore.

    31 Mar 2023

  • Director Appointment

    Duraisami Sathishkannan was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 9 months .

    23 Mar 2021

  • Director Appointment

    Suresh Babu Roshan Vijay was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 9 months .

    23 Mar 2021

  • Director Appointment

    Kuppuraj Shanmugavadivu was appointed as a Director was appointed as a Director on 23 Mar 2021 & has been associated with this company since 3 years 9 months .

    23 Mar 2021

  • Company Incorporation

    Resona Pharmaceutical Limited was registered on 23 Mar 2021 with Roc Coimbatore & aged 3 years 9 months as per MCA records.

    23 Mar 2021

Frequently asked questions

  • Resona Pharmaceutical Limited was incorporated on 23 Mar 2021.

  • The authorized share capital of Resona Pharmaceutical Limited is ₹ 1.00 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Resona Pharmaceutical Limited.

    • Duraisami Sathishkannan
    • Suresh Babu Roshan Vijay
    • Kuppuraj Shanmugavadivu
  • As per Ministry of Corporate Affairs (Mca), the registered address of Resona Pharmaceutical Limited is 253/8 Arun Nagar Annexe Iyer Thottam Periyapuddur, India, Salem, Tamil Nadu, 636016.

  • The corporate identification number (CIN) of Resona Pharmaceutical Limited is U33110TZ2021PLC035879 and the company number is 035879 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Resona Pharmaceutical Limited is https://www.resonapharma.com

  • According to the financial reports for the fiscal year 2023, the revenue trend for Resona Pharmaceutical Limited has risen by 29.54%.

  • The financial reports for the fiscal year 2023 indicates that The net worth of Resona Pharmaceutical Limited has experienced an upsurge of 119.74%.

  • The most recent Balance Sheet for Resona Pharmaceutical Limited was filed with the ROC on 31 Mar 2023.

Similar Companies Based on Drug Formulation & Development